Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.

Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC.

Am J Psychiatry. 2001 Oct;158(10):1617-22.

PMID:
11578993
2.
3.

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

Goodwin FK, Prange AJ Jr, Post RM, Muscettola G, Lipton MA.

Am J Psychiatry. 1982 Jan;139(1):34-8.

PMID:
7055275
4.

Gender differences in treatment response to sertraline versus imipramine in chronic depression.

Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.

Am J Psychiatry. 2000 Sep;157(9):1445-52.

PMID:
10964861
5.

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.

Aronson R, Offman HJ, Joffe RT, Naylor CD.

Arch Gen Psychiatry. 1996 Sep;53(9):842-8.

PMID:
8792761
6.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
7.

Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.

Garbutt JC, Mayo JP Jr, Gillette GM, Little KY, Mason GA.

Am J Psychiatry. 1986 Aug;143(8):1038-9.

PMID:
3089033
9.

Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

Tollefson GD, Holman SL, Sayler ME, Potvin JH.

J Clin Psychiatry. 1994 Feb;55(2):50-9.

PMID:
8077155
10.

Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.

Thase ME, Kupfer DJ, Jarrett DB.

J Clin Psychiatry. 1989 Oct;50(10):385-8.

PMID:
2676995
12.

Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.

Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.

J Psychiatr Res. 2009 Apr;43(7):702-10. doi: 10.1016/j.jpsychires.2008.10.004. Epub 2008 Nov 26.

PMID:
19038406
13.

Failure of T3 to potentiate tricyclic antidepressant response.

Gitlin MJ, Weiner H, Fairbanks L, Hershman JM, Friedfeld N.

J Affect Disord. 1987 Nov-Dec;13(3):267-72.

PMID:
2960719
14.

[The use of thyroid hormones in the treatment of depression].

Cooper R, Lerer B.

Harefuah. 2010 Aug;149(8):529-34, 550, 549. Review. Hebrew.

PMID:
21341434
15.

Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.

Kocsis JH, Croughan JL, Katz MM, Butler TP, Secunda S, Bowden CL, Davis JM.

Am J Psychiatry. 1990 May;147(5):621-4.

PMID:
2183635
16.

Efficacy in long-term treatment of depression.

Montgomery SA.

J Clin Psychiatry. 1996;57 Suppl 2:24-30. Review.

PMID:
8626360
17.
18.
19.

T3 and lithium potentiation of tricyclic antidepressants.

Joffe RT.

Am J Psychiatry. 1988 Oct;145(10):1317-8. No abstract available.

PMID:
3138921
20.

A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.

Bremner JD.

J Clin Psychiatry. 1995 Nov;56(11):519-25.

PMID:
7592505

Supplemental Content

Support Center